Your browser doesn't support javascript.
loading
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity.
Mirlekar, Bhalchandra; Wang, Yan; Li, Sirui; Zhou, Mi; Entwistle, Sarah; De Buysscher, Tristan; Morrison, Ashley; Herrera, Gabriela; Harris, Cameron; Vincent, Benjamin G; Ting, Jenny P-Y; Rashid, Naim; Kim, William Y; Yeh, Jen Jen; Pylayeva-Gupta, Yuliya.
Afiliación
  • Mirlekar B; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Wang Y; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Li S; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Zhou M; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Entwistle S; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • De Buysscher T; Bioinformatics and Analytics Research Collaborative, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Morrison A; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Herrera G; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Harris C; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Vincent BG; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Ting JP; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Genetics, The Universit
  • Rashid N; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Biostatistics, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Kim WY; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Medicine-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Yeh JJ; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Surgery, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Pylayeva-Gupta Y; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA; Department of Genetics, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Electronic address: yuliyap1@email.unc.edu.
Cell Rep Med ; 3(9): 100744, 2022 09 20.
Article en En | MEDLINE | ID: mdl-36099917
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos